nimustine has been researched along with Malignant Melanoma in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (37.93) | 18.7374 |
1990's | 14 (24.14) | 18.2507 |
2000's | 12 (20.69) | 29.6817 |
2010's | 10 (17.24) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiba, S; Fujimura, T; Furudate, S; Kakizaki, A; Kambayashi, Y; Lyu, C; Sato, Y; Tanita, K | 1 |
Akiyama, M; Matsumoto, T; Nin-Asai, R; Saito, S; Sawada, M; Yokota, K | 1 |
Musha, A; Nakano, T; Ohno, T; Saitoh, JI; Shirai, K; Yokoo, S | 1 |
Kitai, R; Kodera, T; Kubota, T; Sato, K; Takeuchi, H; Yoshida, K | 1 |
Kawano, N; Kihara, Y; Kume, K; Otsuki, M; Syukuwa, K; Taguchi, M; Tashiro, M; Yamasaki, M; Yoshikawa, I | 1 |
Mori, K; Nakao, Y; Wada, R; Watanabe, M; Yamamoto, T | 1 |
Fuse, H; Imamura, Y; Nohara, T; Sakai, A | 1 |
Bito, T; Ikeda, T; Nishigori, C; Nishitani, N; Tokura, Y | 1 |
Doi, H; Iizuka, H; Ishida-Yamamto, A; Ito, Y; Tsuji, H | 1 |
Hatanaka, K; Hidemura, A; Ishimaru, M; Kojima, T; Sasaki, S; Uekusa, T | 1 |
Fu, JH; Huang, XY; Li, Y; Wang, X; Xie, X; Yu, H; Zhang, LJ; Zhou, JL | 1 |
Ikeya, T; Nitta, Y; Sakakibara, A; Tomita, Y | 1 |
Abe, N; Irisawa, R; Kurashige, Y; Saito, M; Tsuboi, R | 1 |
Akiyama, S; Fukushige, T; Gunshin, K; Ikeda, R; Kanekura, T; Kawai, K; Matsushita, S; Okumura, H; Tajitsu, Y; Takeda, Y; Ushiyama, M; Yamada, K | 1 |
Ide, H; Nakamura, T | 1 |
Apostolidis, C; Rapidis, AD; Valsamis, S; Vilos, G | 1 |
Aoyama, N; Minamide, J; Ogata, T; Suzuki, Y; Takata, K | 1 |
Fukunaga, T; Kageshita, T; Kojima, S; Ogawa, H; Ono, T; Sakamoto, T; Soejima, H; Sugamura, K; Sugiyama, S; Tanoue, T; Yoshimura, M | 1 |
Iwai, T; Kawada, K; Kawano, T; Nagai, K; Nakajima, Y; Nishikage, T; Ogiya, K; Tanaka, K; Tokairin, Y | 1 |
Komatsubara, H; Komori, T; Minamikawa, T; Ojima, Y; Shibuya, Y; Shigeta, T; Umeda, M; Yokoo, S | 1 |
Ikeda, S; Miura, T; Miyasato, H; Suzuki, T; Tajima, K; Terakado, T | 1 |
Fujimoto, S; Ogawa, M | 1 |
Ichihashi, M; Inoi, T; Mishima, Y; Mojamdar, M | 1 |
Hattori, T; Niimoto, M; Nosoh, Y; Tani, T; Toge, T; Yamaguchi, M; Yoshinaka, K | 1 |
Jimbow, K; Kawamura, M; Maeda, K; Miura, S | 1 |
Kukita, A; Ohara, K; Shimada, S; Someya, T; Yamada, K | 3 |
Harada, M; Komi, N; Makinoya, T; Miyamoto, H; Miyoshi, Y; Tamura, T; Yamamoto, M | 1 |
Hayasaka, K; Ikeda, S; Ishihara, K; Jimbow, K; Kukita, A; Seki, Y; Suzuki, M; Terakado, T | 1 |
Fujimoto, S; Hoshino, A; Ogawa, M | 1 |
Haruyama, H; Ijichi, H; Isemura, T; Nakagawa, M; Nakanishi, S; Okano, R; Sawada, S; Shimazaki, C; Tsuji, H; Ueda, K | 1 |
Aiba, K; Domyo, M; Ezaki, K; Horikoshi, N; Inagaki, J; Inoue, K; Miyamoto, H; Nagata, T; Ogawa, M | 1 |
Jimbow, K; Nishio, C; Yanbe, H | 1 |
Chiba, M; Homma, K; Jimbow, K; Kizukuri, K | 1 |
Hayasaka, K; Ikeda, S; Ishihara, K; Jimbow, K; Kukita, A; Seki, Y; Takahashi, H; Terakado, T | 1 |
Ishihara, K | 1 |
Kishimoto, S; Ueda, E; Yasuno, H | 1 |
Asano, K; Ishihara, K; Yamazaki, N | 1 |
Baba, N; Ichiyama, S; Matsuzaki, T; Miyagawa, K; Miyazawa, M; Nagatani, T; Nakajima, H; Onuma, R; Uchiyama, M | 1 |
Vuoristo, MS | 1 |
Saida, T | 1 |
Dekio, S; Hayashi, S; Ohno, T; Takata, Y | 1 |
Aoki, K; Hayashi, O; Nishioka, K; Ohara, H; Tanaka, K; Umeda, T; Yokoyama, A | 1 |
Haisa, M; Hara, K; Kamikawa, Y; Kenzo, A; Naomoto, Y; Perdomo, JA; Taguchi, K; Tanaka, N; Yamatsuji, T | 1 |
Ishikawa, M; Wada, T; Yamamoto, A; Yamazaki, N | 1 |
Kageshita, T; Kuribayashi, N; Ono, T | 1 |
Akiya, Y; Hagiwara, N; Matsutani, T; Miyashita, M; Onda, M; Sasajima, K; Takubo, K; Yamashita, K | 1 |
Ichiyama, S; Miyakawa, K; Nagatani, T; Uchiyama, M | 1 |
Kan, S; Miyasaka, Y; Murata, K; Ohbu, M; Saito, M; Takagi, H; Takano, S; Yada, K | 1 |
Gröhn, P; Hakala, T; Heikkinen, M; Jakobsson, M; Korpela, M; Kumpulainen, E; Numminen, S; Nuortio, L; Salmi, R; Vuoristo, MS | 1 |
Nogita, T; Otsuka, F; Someya, T; Tsuchida, T; Watanabe, R; Yamada, K | 1 |
Ikegawa, S; Ishihara, K | 1 |
Hamburger, AW; Hoshi, A; Ishihara, J; Ozaki, A; Saijo, N; Sakurai, M; Sasaki, Y; Takahashi, H | 1 |
Abe, H; Doi, S; Murai, H; Sawamura, Y; Tashiro, K | 1 |
Fujisaki, S; Inoue, S; Maeyama, M; Munemura, M; Shibata, S; Tohya, T | 1 |
Hoshi, A; Ishihara, J; Ozaki, A; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Takahashi, H | 1 |
Kukita, A; Nakagawa, H; Shimada, S; Someya, T; Tanaka, N; Tokita, H; Yamada, K | 1 |
5 review(s) available for nimustine and Malignant Melanoma
Article | Year |
---|---|
[Metastatic malignant melanoma of the urinary bladder: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Interferon-beta; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nimustine; Skin Neoplasms; Urinary Bladder Neoplasms; Vincristine | 2009 |
[Malignant melanoma of the alimentary tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Esophageal Neoplasms; Female; Humans; Male; Melanoma; Nimustine; Rectal Neoplasms; Vincristine | 2003 |
[Chemotherapy of malignant melanoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Humans; Immunotherapy, Adoptive; Melanoma; Neoplasm Metastasis; Nimustine; Peplomycin; Vincristine | 1995 |
[Treatment of malignant melanoma: recent advances and perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Melanoma; Nimustine; Skin Neoplasms; Tamoxifen; Vincristine | 1997 |
[An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Male; Melanoma; Nevus, Pigmented; Nimustine; Nitrosourea Compounds; Skin Neoplasms; Vincristine | 1987 |
5 trial(s) available for nimustine and Malignant Melanoma
Article | Year |
---|---|
Chemoimmunotherapy for melanoma with DTIC, ACNU, VCR and OK432: evaluation of new combinations for survival rates, side effects and cellular immunity.
Topics: Biological Products; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; Immunotherapy; Male; Melanoma; Nimustine; Nitrosourea Compounds; Picibanil; Vincristine | 1981 |
The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Hutchinson's Melanotic Freckle; Interferon-beta; Melanoma; Nimustine; Skin Neoplasms; Survival Rate; Vincristine | 1995 |
Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Nimustine; Recombinant Proteins; Treatment Outcome; Vincristine | 1996 |
Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Chemotherapy, Adjuvant; Dacarbazine; Female; Flow Cytometry; Humans; Injections, Intralesional; Injections, Intravenous; Interferon-beta; Killer Cells, Natural; Leukocyte Count; Male; Melanoma; Middle Aged; Nimustine; Skin Neoplasms; Statistics, Nonparametric; T-Lymphocytes; Treatment Outcome; Vincristine | 1998 |
A phase II study of metastatic melanoma treated with a combination of interferon alfa 2b, dacarbazine and nimustine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Nimustine; Recombinant Proteins | 1992 |
48 other study(ies) available for nimustine and Malignant Melanoma
Article | Year |
---|---|
Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; B7-H1 Antigen; Dacarbazine; Female; Japan; Lectins, C-Type; Leukocytes, Mononuclear; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monocytes; Nimustine; Receptors, Cell Surface; RNA, Messenger; Skin Neoplasms; Vincristine | 2018 |
Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Humans; Male; Melanoma; Myelodysplastic Syndromes; Nimustine; Skin Neoplasms | 2014 |
Oral mucosal melanoma treated with carbon ion radiotherapy: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Dacarbazine; Heavy Ion Radiotherapy; Humans; Male; Melanoma; Mouth Mucosa; Mouth Neoplasms; Mucous Membrane; Neoplasm Recurrence, Local; Nimustine; Radiation Injuries; Radiotherapy Dosage; Treatment Outcome; Vincristine | 2016 |
Melanocytoma in the orbital apex.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Diagnosis, Differential; Humans; Immunohistochemistry; Interferon-beta; Male; Melanocytes; Melanoma; Meningeal Neoplasms; Middle Aged; Neurosurgical Procedures; Nimustine; Orbital Neoplasms; Tomography, X-Ray Computed; Vincristine | 2009 |
[Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cisplatin; Dacarbazine; Humans; Interferon-beta; Liver Neoplasms; Male; Melanoma; Neoplasm Staging; Nimustine; Rectal Neoplasms; Tamoxifen; Treatment Outcome | 2008 |
Intra-axial brainstem malignant melanoma mimicking cavernous angioma--case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Diseases; Craniotomy; Dacarbazine; Diagnosis, Differential; Female; Hemangioma, Cavernous, Central Nervous System; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Melanoma; Nimustine; Radiotherapy, Adjuvant; Reoperation; Tamoxifen | 2008 |
Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
Topics: Antineoplastic Agents; Dacarbazine; Disease-Free Survival; Humans; Interferon-beta; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nimustine; Osteomyelitis; Skin Neoplasms; Vincristine; Vitiligo | 2010 |
Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Fatal Outcome; Female; Humans; Interferon-beta; Iofetamine; Liver Neoplasms; Lung Neoplasms; MART-1 Antigen; Mastectomy, Modified Radical; Melanoma; Middle Aged; Neoplasm Staging; Nimustine; Nipples; Radiopharmaceuticals; S100 Proteins; Skin Neoplasms; Tamoxifen; Tomography, Emission-Computed, Single-Photon; Vincristine | 2010 |
[A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Combined Modality Therapy; Dacarbazine; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nimustine; Remission Induction; Tomography, X-Ray Computed; Vincristine | 2010 |
Primary malignant melanoma of the esophagus: a study of clinical features, pathology, management and prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Nimustine; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 2011 |
Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Female; Foot Diseases; Humans; Melanoma; Middle Aged; Myelodysplastic Syndromes; Nimustine; Retrospective Studies; Vincristine | 2011 |
Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Foot Diseases; Humans; Interferon-beta; Melanoma; Nimustine; Skin Neoplasms; Skin Ulcer; Vincristine | 2012 |
p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nimustine; Prognosis; Ribonucleotide Reductases; RNA Interference; Skin Neoplasms; Transfection; Vincristine; Young Adult | 2012 |
Primary malignant melanoma of the oral mucosa.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neck Dissection; Nimustine; Retrospective Studies; Vincristine | 2003 |
Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Humans; Infusions, Intravenous; Interferon-beta; Male; Melanoma; Middle Aged; Nimustine; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Cisplatin; Coronary Artery Disease; Dacarbazine; Drug Administration Schedule; Female; Humans; Melanoma; Middle Aged; Myocardial Infarction; Nimustine; Skin Neoplasms; Tamoxifen | 2006 |
Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Injections, Intralesional; Interferon-beta; Melanoma; Middle Aged; Nimustine; Vincristine | 2007 |
Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Contraindications; Dacarbazine; Female; Humans; Immunotherapy; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Nimustine; Picibanil; Prognosis; Risk Factors; Tooth Extraction; Vincristine | 2008 |
[New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Administration Schedule; Female; Humans; Melanoma; Nimustine; Nitrosourea Compounds; Peplomycin; Skin Neoplasms; Vincristine | 1983 |
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin | 1982 |
[Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Prognosis; Vincristine | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Synergism; Fluorouracil; Humans; Interferon Type I; Male; Melanoma; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Stomach Neoplasms | 1984 |
[Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Indomethacin; Lung Neoplasms; Male; Melanoma; Nimustine; Nitrosourea Compounds; Pain, Intractable; Picibanil; Skin Neoplasms; Suppositories; Vincristine | 1984 |
[Thermochemotherapy for malignant melanoma--combination therapy of ACNU and hyperthermia in mice].
Topics: Animals; Antineoplastic Agents; Hot Temperature; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Skin Neoplasms | 1983 |
Thermochemotherapy for malignant melanoma: combination therapy of ACNU and hyperthermia in mice.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Humans; Hyperthermia, Induced; Male; Melanoma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds | 1984 |
[Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Nimustine; Nitrosourea Compounds; Picibanil; Vincristine | 1984 |
[Thermochemotherapy for malignant melanoma--combined therapy of anti-tumor agents and hyperthermia in mice].
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Doxorubicin; Hyperthermia, Induced; Male; Melanoma; Mice; Mice, Inbred C57BL; Nimustine; Nitrosourea Compounds; Skin Neoplasms; Triazenes | 1984 |
[Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Child; Dacarbazine; Female; Foot; Hand; Humans; Japan; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Skin Neoplasms; Vincristine | 1984 |
Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Lung Neoplasms; Male; Melanoma; Mercaptopurine; Mice; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Thioguanine | 1980 |
[A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
Topics: Adult; Biological Products; Dacarbazine; Drug Therapy, Combination; Female; Humans; Melanoma; Nimustine; Nitrosourea Compounds; Picibanil; Skin Neoplasms; Vincristine | 1982 |
[A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma].
Topics: Adult; Aged; Dacarbazine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Skin Neoplasms | 1982 |
Chemoimmunotherapy for disseminated malignant melanoma with DTIC, ACNU, VCR and OK432. Case presentation of two complete and one partial reponse out of fifteen attempts.
Topics: Adjuvants, Immunologic; Adult; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Nimustine; Nitrosourea Compounds; Picibanil; Skin Neoplasms; Vincristine | 1982 |
[Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Therapy, Combination; Female; Humans; Leucine; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Skin Neoplasms; Vincristine | 1982 |
Statistical survey from 1982 to 1991 of 49 patients with malignant melanocytic tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Dacarbazine; Female; Humans; Interferon-beta; Male; Melanoma; Middle Aged; Nimustine; Prognosis; Skin Neoplasms; Survival Rate; Vincristine | 1995 |
[Chemotherapy of malignant melanoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Melanoma; Middle Aged; Nimustine; Peplomycin; Skin Neoplasms; Vincristine | 1993 |
Paralytic ileus associated with a combination of dacarbazine-nimustine hydrochloride-vincristine chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Intestinal Pseudo-Obstruction; Melanoma; Nimustine; Skin Neoplasms; Vincristine | 1997 |
Primary malignant melanoma of the esophagus: report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Humans; Lymph Node Excision; Male; Melanoma; Middle Aged; Nimustine; Tamoxifen | 1998 |
Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Nimustine; Skin Neoplasms; Tamoxifen; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dacarbazine; Humans; Leukocyte Count; Male; Melanoma; Middle Aged; Myelodysplastic Syndromes; Nimustine; Skin Neoplasms; Vincristine | 2000 |
Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Follow-Up Studies; Humans; Male; Melanoma; Nimustine; Treatment Outcome; Vincristine | 2001 |
Malignant melanoma treated with natural interferons alfa and beta and DAV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Interferon-alpha; Interferon-beta; Male; Melanoma; Middle Aged; Nimustine; Vincristine | 1992 |
[Primary intracranial melanoma: a case report].
Topics: Adult; Amphetamines; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Dacarbazine; Diagnosis, Differential; Humans; Interferon-beta; Iodine Radioisotopes; Iofetamine; Magnetic Resonance Imaging; Male; Melanoma; Nimustine; Prognosis; Tomography, Emission-Computed, Single-Photon; Vincristine | 1992 |
Antiproliferative effect of hyperthermia and ACNU on cultured human malignant melanoma cells.
Topics: Cell Count; Cell Division; Combined Modality Therapy; Hot Temperature; Humans; Hyperthermia, Induced; Melanoma; Nimustine; Tumor Cells, Cultured | 1990 |
[Diagnosis and treatment of malignant melanoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Humans; Lymph Node Excision; Melanoma; Nimustine; Nitrosourea Compounds; Peplomycin; Prognosis; Skin; Skin Neoplasms; Vincristine | 1985 |
Reduction of pulmonary metastases of B16 melanoma by human recombinant interleukin 2 and lymphokine-activated killer cells in immunosuppressed C57BL/6 mice receiving anticancer agent.
Topics: Animals; Cytotoxicity, Immunologic; Immune Tolerance; Immunization, Passive; Immunotherapy; Interleukin-2; Killer Cells, Natural; Kinetics; Lung Neoplasms; Lymphocytes; Male; Melanoma; Mice; Mice, Inbred C57BL; Nimustine; Nitrosourea Compounds; Recombinant Proteins | 1986 |
[Adjuvant chemotherapy of malignant melanoma of the female genital organs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Picibanil; Vaginal Neoplasms; Vincristine; Vulvar Neoplasms | 1986 |
[Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
Topics: Animals; Immunization, Passive; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Nimustine; Nitrosourea Compounds; Recombinant Proteins | 1986 |
Thermochemotherapy for malignant melanoma: overcoming heterogeneity in drug sensitivity.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Drug Resistance; Hyperthermia, Induced; Male; Melanoma; Mice; Mice, Inbred BALB C; Nimustine; Nitrosourea Compounds; Skin Neoplasms; Time Factors | 1985 |